Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications. Schwartz GG, Cobbaert CM. J Am Coll Cardiol 2025;85:1855-1857.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schwartz GG, Cobbaert CM. Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications. J Am Coll Cardiol 2025;85:1855-1857.
PMID: 40368574